Taiho Oncology, Inc.
Caroline Jean has over 25 years of experience in the pharmaceutical industry. Caroline started their career with Roche in 1995 as a Hybrid Pharmaceutical representative and then became a Senior Pharmaceutical Sales representative, specializing in CARDIOLOGY, PSYCHIATRY, ORTHOPEDY, ENDOCRINOLOGY, and DERMATOLOGY. Caroline then joined Servier Canada as a Therapeutic Specialist in various fields including RHUMATOLOGY, CARDIOLOGY, ENDOCRINOLOGY, and PSYCHIATRY.
Caroline later joined Astellas Pharma as a Specialist Therapeutic in UROLOGY and DERMATOLOGY, and then moved to Roche as a Therapeutic Specialist in ONCOLOGY, focusing on LUNG cancer. Caroline then became a Senior Therapeutic Specialist in ONCOLOGY, specializing in LUNG and DERMATOLOGY.
Caroline's next move was to Bayer, where they served as a Senior Therapeutic Specialist in OPHTHALMOLOGY and then as a Senior ONCOLOGY Therapeutic Specialist, covering GI, GIST, HCC, and PROSTATE cancer.
Afterwards, Caroline joined AstraZeneca as a Therapeutic Specialist in ONCOLOGY, specifically focusing on LUNG and PROSTATE cancer. Caroline then moved to Sanofi Genzyme as a Key Account Specialist in ONCOLOGY.
Their most recent position is at Taiho Oncology, Inc., where they work as an Oncology Clinical Science Associate. Caroline is responsible for various tasks related to clinical research and development in the field of oncology.
Throughout their career, Caroline has gained extensive expertise in various therapeutic areas, including oncology, ophthalmology, urology, dermatology, cardiology, rheumatology, endocrinology, psychiatry, and infectious diseases.
Caroline Jean attended Champlain Regional College from 1988 to 1990, where they pursued a degree in Health Sciences. Following their time at Champlain, Caroline went on to study at the Université de Sherbrooke from 1991 to 1994, earning a Bachelor of Science degree in Biology.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com